Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-003065
Filing Date
2015-01-08
Accepted
2015-01-08 12:44:52
Documents
2
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3244
2 POA DOCUMENT poa.txt EX-24.5_554098 3310
  Complete submission text file 0001209191-15-003065.txt   8074
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MABVAX THERAPEUTICS HOLDINGS, INC. 11588 SORRENTO VALLEY ROAD, SUITE 20 SAN DIEGO CA 92121
Business Address
MAFFUID PAUL W (Reporting) CIK: 0001170363 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-31265 | Film No.: 15515632